马来西亚股票分析报告

A leading specialty chemical group is exhibiting robust operational momentum and aggressively advancing strategic expansion initiatives, leading to an upgraded investment recommendation. TA SECURITIES has raised its target price and issued a BUY rating for the stock, anticipating long-term margin expansion driven by a strategic pivot and cost efficiencies.

Financial Performance Review

For FY25, the group reported a c.16% year-on-year increase in revenue, reaching approximately RM184 million, underpinned by strong production output. However, Profit Before Tax (PBT) saw a notable decline of 62% to roughly RM13 million, compared to RM21 million in FY24. This contraction was primarily due to one-off listing expenses and significant net foreign exchange losses, amounting to RM1.4 million and RM3.6 million respectively. Gross profit margin also narrowed by 4 percentage points. Management noted that about 60% of the group’s earnings are USD-denominated.

Operational Landscape and Challenges

The group operated at approximately 40% utilization of its total production capacity. While output volume grew by an estimated 17%, this did not fully translate into stronger top-line growth. This was largely influenced by the appreciation of the Ringgit against the USD and a strategic decision to lower average selling prices in pursuit of market share expansion. Despite ongoing geopolitical conflicts, including the Middle East, the group affirmed that business operations continued as usual, with an estimated 80% of its revenue derived from the Asia Pacific and American regions. Localized logistical delays were reported due to shipping disruptions, but order flow from the Middle East remains intact, viewed as timing-based bottlenecks rather than a loss of demand.

Strategic Growth and Future Outlook

The group is actively pursuing a multi-pronged growth strategy across several key facilities and projects. The newly acquired warehouse facility at the Puncak Alam Integrated Complex commenced utilization in 3QFY25, with full renovation of the corporate office and warehouse expected by early-April 2026. Operations for a 3-year specialized supply contract with Pengerang Refining Company Sdn Bhd (PRCSB) are scheduled to begin in April-May 2026, involving the supply of Di-tert-butyl Polysulfide (TBPS) and Ethyl Mercaptan (EM).

Further expansion includes a strategic partnership with CoolisT Group for specialty additives and bio-polyols in China, targeting Q2 2026, and a transition into a Technology Partner for the Wet Gas Sulphuric Acid (WSA) facility project in Indonesia, with its next phase under a Build-Own-Operate-Transfer (BOOT) model kicking off in Q2 2026. Additionally, the group is advancing its toll-manufacturing strategy in the U.S. market, leveraging recently granted USPTO patents for sand agglomeration chemicals by 1HFY26 to localize production and mitigate shipping overheads. These initiatives are being complemented by an internal cost-rationalization exercise and the centralization of operations at the new Puncak Alam facility, designed to optimize the group’s cost structure and drive long-term margin expansion.

Earnings Revisions and Investment Recommendation

TA SECURITIES has revised its FY26E earnings upwards by 21%. This adjustment primarily reflects the absence of one-off listing expenses from FY25, lower forex volatility due to a stable USD/MYR outlook, a higher effective tax rate assumption of 29% (from 24% previously), and a 2 percentage point increase in output growth assumption to 3%, driven by stronger contributions from Asia-Pacific and American markets. These positive factors are partially offset by lower assumed selling prices and the normalization of the Ringgit, which together reduce the top-line by approximately 15%.

For FY27E, earnings estimates were cut by 35% due to lower assumed selling prices and a normalized Ringgit, though this is partly cushioned by an unchanged output growth of 4%. Based on a revised FY26E EPS of 0.77 sen (previously 0.63 sen) and a lower target PER of 17.2x (from 17.5x), the investment bank derived a new Target Price of RM0.132 (previously RM0.110). Citing undemanding valuations (as FY26E P/BV < 1.0x), the stock has been upgraded to a BUY recommendation.

Investment Case and Risks

The long-term outlook for the group remains positive, underpinned by its defensible market position and strategic diversification. Its core strength lies in robust institutional ties, with its top four global Oil & Gas clients, led by Petronas, accounting for 78% of revenue from the Asia-Pacific and American regions. Beyond its legacy portfolio, the group is pivoting towards high-growth industrial applications, including bio-based lubricants and transformer oils, supported by a dual-track strategy: geographical scaling with new production facilities and innovation-led growth via partnerships leveraging palm-based polyols. Key risks to the recommendation include dependence on key customers, foreign currency exposure, and raw materials input cost fluctuation.